ANAPLASTIC LARGE-CELL LYMPHOMA

ANAPLASTIC LARGE-CELL LYMPHOMA was reported 236 times

ANAPLASTIC LARGE-CELL LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CD30-directed Immunoconjugate [EPC] 86 0.0083
1 CCR5 Co-receptor Antagonist [EPC] 3 0.0013
2 Monobactam Antibacterial [EPC] 1 0.0004
3 Anthelmintic [EPC] 1 0.0003
4 CD33-directed Immunoconjugate [EPC] 1 0.0003
5 Topoisomerase Inhibitor [EPC] 16 0.0002
6 Antimalarial [EPC] 2 0.0002
7 Antiprotozoal [EPC] 2 0.0002
8 Alkylating Drug [EPC] 41 0.0002
9 Purine Antimetabolite [EPC] 15 0.0002
10 Cannabinoid [EPC] 1 0.0001
11 Interleukin-1 Receptor Antagonist [EPC] 2 0.0001
12 Interleukin-12 Antagonist [EPC] 12 0.0001
13 Interleukin-23 Antagonist [EPC] 12 0.0001
14 Thyroid Hormone Synthesis Inhibitor [EPC] 1 0.0001
15 Anti-anginal [EPC] 1 0.0001
16 Integrin Receptor Antagonist [EPC] 8 0.0001
17 Folate Analog Metabolic Inhibitor [EPC] 36 0.0001
18 PCSK9 Inhibitor [EPC] 2 0.0001
19 Melatonin Receptor Agonist [EPC] 1 0.0001
20 Protease Inhibitor [EPC] 3 0.0001
21 Corticosteroid [EPC] 76 0.0001
22 Nitrofuran Antibacterial [EPC] 1 0.0001
23 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
24 Interleukin-17A Antagonist [EPC] 2 0.0001
25 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 5 0.0001
26 CD52-directed Cytolytic Antibody [EPC] 1 0.0001
27 Cytochrome P450 3A Inhibitor [EPC] 3 0.0000
28 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
29 Aluminum Complex [EPC] 1 0.0000
30 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
31 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
32 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 4 0.0000
33 Provitamin D2 Compound [EPC] 1 0.0000
34 Phenothiazine [EPC] 1 0.0000
35 Oxazolidinone Antibacterial [EPC] 1 0.0000
36 Azole Antifungal [EPC] 5 0.0000
37 Penem Antibacterial [EPC] 1 0.0000
38 Xanthine Oxidase Inhibitor [EPC] 4 0.0000
39 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
40 Dietary Cholesterol Absorption Inhibitor [EPC] 2 0.0000
41 Kinase Inhibitor [EPC] 12 0.0000
42 Tumor Necrosis Factor Blocker [EPC] 21 0.0000
43 Janus Kinase Inhibitor [EPC] 3 0.0000
44 Nucleoside Metabolic Inhibitor [EPC] 5 0.0000
45 Interleukin-4 Receptor alpha Antagonist [EPC] 8 0.0000
46 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
47 Tetracycline-class Drug [EPC] 1 0.0000
48 Osmotic Laxative [EPC] 4 0.0000
49 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
50 Catecholamine [EPC] 1 0.0000
51 Nucleoside Analog Antiviral [EPC] 1 0.0000
52 Atypical Antipsychotic [EPC] 5 0.0000
53 Platinum-based Drug [EPC] 3 0.0000
54 Interferon beta [EPC] 2 0.0000
55 Proton Pump Inhibitor [EPC] 6 0.0000
56 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
57 Aminosalicylate [EPC] 1 0.0000
58 5-alpha Reductase Inhibitor [EPC] 1 0.0000
59 Thiazide Diuretic [EPC] 2 0.0000
60 Vitamin B12 [EPC] 3 0.0000
61 Fluoroquinolone Antibacterial [EPC] 1 0.0000
62 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
63 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
64 Factor Xa Inhibitor [EPC] 2 0.0000
65 Vitamin C [EPC] 3 0.0000
66 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
67 Vitamin D [EPC] 2 0.0000
68 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
69 Retinoid [EPC] 1 0.0000
70 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
71 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
72 Loop Diuretic [EPC] 1 0.0000
73 Thalidomide Analog [EPC] 1 0.0000
74 Benzodiazepine [EPC] 1 0.0000